J.K. Chemlabs Profile
Key Indicators
- Authorised Capital ₹ 7.80 Cr
as on 06-12-2024
- Paid Up Capital ₹ 7.80 Cr
as on 06-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.88 Cr
as on 06-12-2024
- Revenue %
(FY 2021)
- Profit 80.72%
(FY 2021)
- Ebitda 81.08%
(FY 2021)
- Net Worth -8.26%
(FY 2021)
- Total Assets 31.82%
(FY 2021)
About J.K. Chemlabs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.80 Cr and a paid-up capital of Rs 7.80 Cr.
The company currently has active open charges totaling ₹16.88 Cr.
Koti Baireddy, Baireddy Jaya, Ravi Baireddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233TG2011PTC073514
- Company No.
073514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at J.K. Chemlabs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koti Baireddy  | Additional Director | 27-Apr-2019 | Current |
| Baireddy Jaya | Director | 25-Mar-2011 | Current |
| Ravi Baireddy | Director | 04-Dec-2021 | Current |
| Nitya Dasaram | Director | 04-Dec-2021 | Current |
Financial Performance of J.K. Chemlabs.
J.K. Chemlabs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.72% increase in profit. The company's net worth dipped by a decrease of 8.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J.K. Chemlabs?
In 2021, J.K. Chemlabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jayanth Life Sciences Private LimitedActive 13 years 9 monthsKoti Baireddy and Baireddy Jaya are mutual person
- Jayanth Pharmaceuticals Private LimitedActive 22 years 10 months
Koti Baireddy, Baireddy Jaya and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 19 Oct 2022 | ₹16.88 Cr | Open |
How Many Employees Work at J.K. Chemlabs?
Unlock and access historical data on people associated with J.K. Chemlabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J.K. Chemlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J.K. Chemlabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
